Patents by Inventor Jean Bourhis

Jean Bourhis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EGFR INHIBITOR AND ANTIVIRAL AGENT FOR SIMULTANEOUS, SEPARATE OR SEQUENTIAL USE IN THE TREATMENT AND/OR PREVENTION AND/OR PALLIATION OF CANCER
    Publication number: 20130189248
    Abstract: The application relates to a combination of biologically active compounds comprising at least one antiviral agent and at least one EGFR antagonist, for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of malignant or pre-malignant neoplasms, preferably of solid malignant or pre-malignant neoplasms.
    Type: Application
    Filed: March 24, 2011
    Publication date: July 25, 2013
    Inventors: Eric Deutsch, Marie Catherine Vozenin, Jean Bourhis
  • Topical administration of amifostine and related compounds
    Patent number: 7151094
    Abstract: The present invention is directed to methods of treating or protecting mucosal tissue from damage associated with radiation and/or chemotherapeutic treatment of cancers, by the topical application of amifostine and related compounds. These methods avoid the side effects of systemically applied radio/chemo protectants. The invention is also directed to treatment and prevention of infections associated with mucositis by topical application of amifostine and related compounds.
    Type: Grant
    Filed: June 22, 2004
    Date of Patent: December 19, 2006
    Assignee: Medlmmune Oncology, Inc.
    Inventors: Martin Stogniew, Jean Bourhis
  • Topical administration of amifostine and related compounds
    Publication number: 20050282785
    Abstract: The present invention is directed to methods of treating or protecting mucosal tissue from damage associated with radiation and/or chemotherapeutic treatment of cancers, by the topical application of amifostine and related compounds. These methods avoid the side effects of systemically applied radio/chemo protectants. The invention is also directed to treatment and prevention of infections associated with mucositis by topical application of amifostine and related compounds.
    Type: Application
    Filed: June 22, 2004
    Publication date: December 22, 2005
    Inventors: Martin Stogniew, Jean Bourhis
  • Antiviral agent for use in treatment of cancer
    Publication number: 20040192637
    Abstract: The invention relates to an antiviral agent for use in combination with an anticancer agent, for the treatment of cancer. Especially, the invention provides means for the treatment of non-virus-associated cancer.
    Type: Application
    Filed: December 19, 2003
    Publication date: September 30, 2004
    Applicants: INSTITUT GUSTAVE ROUSSY, UNIVERSITE PARIS-SUD XI
    Inventors: Jean Bourhis, Bassam Abdulkarim, Eric Deutsch
  • Topical administration of amifostine and related compounds
    Patent number: 6753323
    Abstract: The present invention is directed to methods of treating or protecting mucosal tissue from damage associated with radiation and/or chemotherapeutic treatment of cancers, by the topical application of amifostine and related compounds. These methods avoid the side effects of systemically applied radio/chemo protectants. The invention is also directed to treatment and prevention of infections associated with mucositis by topical application of amifostine and related compounds.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: June 22, 2004
    Assignee: MedImmune Oncology, Inc.
    Inventors: Martin Stogniew, Jean Bourhis
  • Antiviral agent for use in treatment of cancer
    Patent number: 6723712
    Abstract: The invention relates to an antiviral agent for use in combination with an anticancer agent, for the treatment of cancer. Especially, the invention provides means for the treatment of non-virus-associated cancer.
    Type: Grant
    Filed: May 2, 2002
    Date of Patent: April 20, 2004
    Assignees: Institut Gustave Roussy, Universite Paris-SUD XI
    Inventors: Jean Bourhis, Bassam Abdulkarim, Eric Deutsch
  • Topical administration of amifostine and related compounds
    Publication number: 20030022867
    Abstract: The present invention is directed to methods of treating or protecting mucosal tissue from damage associated with radiation and/or chemotherapeutic treatment of cancers, by the topical application of amifostine and related compounds. These methods avoid the side effects of systemically applied radio/chemo protectants. The invention is also directed to treatment and prevention of infections associated with mucositis by topical application of amifostine and related compounds.
    Type: Application
    Filed: March 28, 2001
    Publication date: January 30, 2003
    Applicant: MedImmune Oncology, Inc.
    Inventors: Martin Stogniew, Jean Bourhis
  • Antiviral agent for use in treatment of cancer
    Publication number: 20020193339
    Abstract: The invention relates to an antiviral agent for use in combination with an anticancer agent, for the treatment of cancer. Especially, the invention provides means for the treatment of non-virus-associated cancer.
    Type: Application
    Filed: May 2, 2002
    Publication date: December 19, 2002
    Applicant: INSTITUT GUSTAVE ROUSSY
    Inventors: Jean Bourhis, Bassam Abdulkarim, Eric Deutsch
  • Topical administration of amifostine and related compounds
    Patent number: 6239119
    Abstract: The present invention is directed to methods of treating or protecting mucosal tissue from damage associated with radiation and/or chemotherapeutic treatment of cancers, by the topical application of amifostine and related compounds. These methods avoid the side effects of systemically applied radio/chemo protectants. The invention is also directed to treatment and prevention of infections associated with mucositis by topical application of amifostine and related compounds.
    Type: Grant
    Filed: April 26, 1999
    Date of Patent: May 29, 2001
    Assignee: MedImmune Oncology, Inc.
    Inventors: Martin Stogniew, Jean Bourhis